First-in-human, phase I study of elisidepsin (PM02734)...

Investigational New Drugs 2015 / 8 Vol. 33; Iss. 4

First-in-human, phase I study of elisidepsin (PM02734) administered as a 30-min or as a 3-hour intravenous infusion every three weeks in patients with advanced solid tumors

Ratain, Mark J., Geary, David, Undevia, Samir D., Coronado, Cinthya, Alfaro, Vicente, Iglesias, Jorge L., Schilsky, Richard L., Miguel-Lillo, Bernardo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-015-0247-1
Date:
August, 2015
File:
PDF, 841 KB
english, 2015
Conversion to is in progress
Conversion to is failed